Amygdaloid and hippocampal β-adrenoceptors in the olfactory bulbectomy syndrome: Effects of desipramine

Annals of the New York Academy of Sciences

Volumn 877, Issue , 1999, Pages 764-768

  Richardson, J Steven ^a,b   Tiong, Alec H K ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; DESIPRAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN CORTEX; CONFERENCE PAPER; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; LIMBIC SYSTEM; MALE; NONHUMAN; OLFACTORY BULBECTOMY; PASSIVE AVOIDANCE; RAT; TIME;

EID: 0032814719     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09319.x     Document Type: Conference Paper

References (13)

1. 1. Watson, J.B. 1906. Kinaesthetic and organic sensations: their role in the reactions of the white rat in the maze. Psychol. Bull. 8; 1-100.
2. 2. Cain, D.P. 1974. The role of the olfactory bulb in limbic mechanisms. Psychol. Bull. 81: 654-671.
3. 3. Leonard, B.E. 1984. The olfactory bulbectomized rat as a model of depression. Pol. J. Pharmacol. 36: 561-569.
4. 4. Jesberger, J.A. & J.S. Richardson. 1985. Animal models of depression: parallels and correlates to severe depression in humans. Biol. Psychiatry 20: 764-784.
5. 5. Van Riezen, H, et al. 1977. Olfactory ablation in the rat: behavioural changes and their reversal by antidepressant drugs. Br. J. Pharmacol, 60: 521-528.
6. 6. McGrath, C. & T.R. Norman. 1998. The effect of venlafaxine treatment on the behavioural and neurochemical changes in the olfactory bulbectomized rat. Psychopharmacology 136: 394-401.
7. 7. Jesberger, J.A, & J.S. Richardson, 1988. Brain output dysrcgulation induced by olfactory bulbectomy: an approximation in the rat of major depressive disorder in humans? Int. J. Neurosci. 38: 241-265.
8. 8. Richardson, J.S, 1991. The olfactory bulbectomized rat as a model of major depression. In Neuromethods: Animal Models in Psychiatry. II. M.T. Martin-Iverson, A.A. Boulton & G.B. Baker, Eds.: 61-79. Humana Press. Clifton, NJ.
9. 9. Richardson, J.S, 1991. Animal models of depression reflect changing views on the essence and etiology of depressive disorders in humans. Prog. Neuropsychopharmacol. Biol. Psychiatry 15: 199-204.
10. 10. Grecksch, G. et al, 1997. Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates. Br. J. Pharmacol. 122: 1725-1731.
11. 11. Kelly, J.P. et al. 1997. The olfactory bulbeclomized rat as a model of depression: an update. Pharmacol. Ther. 74: 299-316.
12. 12. Richardson, J.S. & R.E. Musty. 1974. Effects on the acquisition of DRL-20 performance of propranolol or isoproterenol injected into the basolateral amygdala of rats. Can. J. Physiol. Pharmacol, 52: 1033-1035.
13. 13. Ikegaya, Y. et al. 1997. Amygdala β-noradrenergic influence on hippocarnpal long-term potentiation in vivo. Neuroreport 8: 3143-3146.